Clinical Trial Update: Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab [Phase 3]

View source ↗

Summary

A Phase 3 trial of certolizumab pegol in adults with Crohn's disease who failed infliximab was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Certolizumab Pegol (Cimzia) (certolizumab pegol)

Snippet

Sponsor: UCB Pharma | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2009-10-19